The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,120.00
Bid: 9,120.00
Ask: 9,125.00
Change: -35.00 (-0.38%)
Spread: 5.00 (0.055%)
Open: 9,165.00
High: 9,190.00
Low: 9,030.00
Prev. Close: 9,155.00
SPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of US Thermal Energy Specialist

28 Sep 2022 07:00

RNS Number : 9173A
Spirax-Sarco Engineering PLC
28 September 2022
 

 

News Release

 

28th September 2022

Acquisition of US thermal energy specialist

Spirax-Sarco Engineering plc, the thermal energy management and niche pumping specialist, announces that it has entered into a definitive agreement to acquire Durex International Corporation (Durex), a privately-owned US based specialist in custom electric thermal solutions for ultra-high criticality industrial equipment.

 

The consideration is US$342.2 million on a cash and debt free basis, subject to customary closing adjustments. The transaction will be financed through acquisition bank facilities and will be accretive to Group earnings in 2023. Following regulatory approval, completion is expected in October 2022.

 

Durex was founded in 1980 and has close to 380 employees most of whom are located at its headquarters and three manufacturing facilities in Cary, Illinois. In 2021, 89% of its sales were to Original Equipment Manufacturers (OEMs), which tend to be highly recurring in nature. Geographically, 87% of sales were generated in North America and 12% in Asia Pacific, with 60% of total sales to OEMs in the Semiconductor sector.

 

Durex has a strong track record of top line growth and profitability. For the 12 months to 31st August 2022, revenues were US$74.5 million, EBITDA was US$25.3 million and EBIT was US$23.5 million. For the full year ended 31st December 2021, revenues were US$61.7 million, EBITDA was US$18.7 million and EBIT was US$17.1 million.

 

Durex provides OEMs with custom-designed precision thermal solutions with embedded electric heating, cooling and sensing technologies. These high criticality solutions are incorporated by the OEMs into complex equipment requiring precise thermal control, such as Semiconductor Wafer Fabrication Equipment (WFE). Durex is well positioned to capitalise on the growing trend of increasingly stringent thermal demands in high technology equipment and processes. 

 

Upon completion, Durex will form part of the Group's Electric Thermal Solutions Business (ETS) which comprises Chromalox, Thermocoax and shortly Vulcanic. Chromalox and Vulcanic will be the lead brands for electric process heating, including decarbonisation of industrial processes. Thermocoax and Durex will be the lead brands for high criticality OEM applications, are highly complementary with minimal customer overlap and will strengthen coverage of the North American and European markets. Durex will accelerate the development of ETS' critical OEM business in attractive market sectors and target application areas, fulfilling key objectives of ETS' growth strategy. 

 

Nicholas Anderson, Group Chief Executive, Spirax-Sarco Engineering plc, said: "We are excited about this opportunity to further strengthen our ETS Business and look forward to welcoming colleagues from Durex into our Group. We have great respect and admiration for Durex that has grown and developed under the skilful leadership of Ed Hinz, who founded the business over 40 years ago. Ed's impending retirement provided an excellent opportunity for us to broaden our capabilities in key target sectors, accelerating the development of our ETS business in line with our long-term plans."

 

 

Enquiries:

Nicholas Anderson, Group Chief Executive

Andrew Guthrie, Head of Investor Relations

 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading Businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions Businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both Businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs more than 9,200 people, including more than 2,000 direct sales and service engineers. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

 

Further information can be found at www.spiraxsarcoengineering.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBKOBDBBKBPCB
Date   Source Headline
1st Nov 20114:27 pmRNSTotal Voting Rights
19th Oct 201112:00 pmRNSDirectorate Change
18th Oct 20119:28 amRNSHolding(s) in Company
17th Oct 20111:58 pmRNSHolding(s) in Company
12th Oct 20113:51 pmRNSDirector/PDMR Shareholding
11th Oct 20114:15 pmRNSTotal Voting Rights
6th Sep 20119:00 amRNSTotal Voting Rights
5th Sep 20115:02 pmRNSDirector/PDMR Shareholding
24th Aug 20114:28 pmRNSDirector/PDMR Shareholding
23rd Aug 20113:54 pmRNSDirector/PDMR Shareholding
23rd Aug 20117:00 amRNS2011 Half Year Results
4th Aug 20115:32 pmRNSNotice of Results
4th Aug 20114:11 pmRNSTotal Voting Rights
27th Jul 20111:03 pmRNSAdditional Listing
12th Jul 20115:14 pmRNSDirector/PDMR Shareholding
6th Jul 20111:47 pmRNSAdditional Listing
1st Jul 201110:43 amRNSTotal Voting Rights
22nd Jun 20114:05 pmRNSDirector/PDMR Shareholding
9th Jun 20119:25 amRNSHolding(s) in Company
6th Jun 20112:49 pmRNSDirector/PDMR Shareholding
6th Jun 20112:46 pmRNSTotal Voting Rights
27th May 20117:00 amRNSDirectorate Change
12th May 20115:23 pmRNSAGM Statement
10th May 20111:00 pmRNSInterim Management Statement
9th May 20111:38 pmRNSHolding(s) in Company
6th May 20114:25 pmRNSTotal Voting Rights
27th Apr 20119:16 amRNSDirector Declaration
6th Apr 20113:34 pmRNSHolding(s) in Company
1st Apr 20114:50 pmRNSDirector/PDMR Shareholding
1st Apr 20114:48 pmRNSTotal Voting Rights
29th Mar 20115:22 pmRNSDirector/PDMR Shareholding
23rd Mar 20114:48 pmRNSAnnual Financial Report
21st Mar 20113:44 pmRNSDirector/PDMR Shareholding
18th Mar 20114:34 pmRNSDirector/PDMR Shareholding
16th Mar 20114:32 pmRNSDirector/PDMR Shareholding
9th Mar 201110:48 amRNSDirector/PDMR Shareholding
8th Mar 20117:00 amRNS2010 Preliminary Results
1st Mar 20119:28 amRNSTotal Voting Rights
3rd Feb 20115:12 pmRNSHolding(s) in Company
1st Feb 201110:52 amRNSTotal Voting Rights
13th Jan 20114:04 pmRNSNotice of Results
5th Jan 201110:06 amRNSTotal Voting Rights
1st Dec 20104:58 pmRNSTotal Voting Rights
15th Nov 20103:24 pmRNSDirector/PDMR Shareholding
8th Nov 20107:00 amRNSInterim Management Statement
1st Nov 20102:08 pmRNSTotal Voting Rights
28th Oct 201010:53 amRNSDirector Declaration
26th Oct 20108:29 amRNSHolding(s) in Company
26th Oct 20108:29 amRNSHolding(s) in Company
19th Oct 20104:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.